Eldred Rock Partners, LLC

Position in MRK — Merck & Co., Inc.

CIK 1984180 SAN ANTONIO, TX

Position in MRK

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$14,959,070

+$1,817,147 QoQ

Shares Held

116,413

+6.6% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

3.22%

of 13F equity value

Holder Rank

#596

of 3,769 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Eldred Rock Partners, LLC holds $35,440,841 across 3 Drug Manufacturers - General names. MRK ranks #1 (42.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc. This page	116,413	$14,959,070
2	NVS	Novartis AG	80,627	$12,635,863
3	NVO	Novo Nordisk A S	163,661	$7,845,908

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$14,959,070	116,413	+6.6%	Shares	Sole	2026-07-08
2026-03-31	$13,141,923	109,252	+1.7%	Shares	Sole	2026-04-08
2025-12-31	$11,306,608	107,416	-11.1%	Shares	Sole	2026-01-16
2025-09-30	$10,145,458	120,880	+12.1%	Shares	Sole	2025-10-21
2025-06-30	$8,538,435	107,863	-4.9%	Shares	Sole	2025-07-09
2025-03-31	$10,185,426	113,474	+10.3%	Shares	Sole	2025-04-09
2024-12-31	$10,231,319	102,848	+0.4%	Shares	Sole	2025-01-16
2024-09-30	$11,635,130	102,458	+4.1%	Shares	Sole	2024-10-04
2024-06-30	$12,189,967	98,465	+4.2%	Shares	Sole	2024-07-12
2024-03-31	$12,467,559	94,487	+1.0%	Shares	Sole	2024-04-11
2023-12-31	$10,198,493	93,547	—	Shares	Sole	2024-01-11
No filing history on record for this holder in this stock.